You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2024

Details for Patent: 8,450,375


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,450,375 protect, and when does it expire?

Patent 8,450,375 protects VALCHLOR and is included in one NDA.

This patent has fifty patent family members in twenty countries.

Summary for Patent: 8,450,375
Title:Stabilized compositions of volatile alkylating agents and methods of using thereof
Abstract: A composition and method for treatment of cancer. The composition for treating a skin disorder, comprising: a Nitrogen Mustard or an HX salt of the Nitrogen Mustard, wherein the Nitrogen Mustard or the HX salt of the Nitrogen Mustard is in a non-aqueous vehicle or carrier that does not include petrolatum or ethanol, wherein the non-aqueous vehicle or carrier that does not include petrolatum or ethanol does not include petrolatum or ethanol. The method comprises topically applying the composition of a Nitrogen Mustard or a HX salt of the Nitrogen Mustard to the affected skin, wherein the Nitrogen Mustard or the HX salt of the Nitrogen Mustard is in a non-aqueous vehicle or carrier that does not include petrolatum or ethanol, wherein the non-aqueous vehicle or carrier does not include petrolatum or ethanol.
Inventor(s): Alonso; Robert (Rye, NH), Crooks; Peter A. (Nicholasville, KY), Pimley; Mark A. (Westchester, PA), Al-Ghananeem; Abeer M. (Lexington, KY)
Assignee: Ceptaris Therapeutics, Inc. (Malvern, PA)
Application Number:11/908,531
Patent Claim Types:
see list of patent claims
Composition; Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,450,375

Introduction

United States Patent 8,450,375, titled "Stabilized compositions of volatile alkylating agents and methods of using thereof," is a patent that addresses the stabilization and application of volatile alkylating agents, particularly in the context of treating skin disorders and cancer. Here, we will delve into the details of the patent's scope, claims, and the broader patent landscape.

Patent Overview

Publication Number and Authority

The patent, US8450375B2, was granted by the United States Patent and Trademark Office (USPTO) and is classified under various chemical and pharmaceutical categories[4].

Inventors and Priority Date

While the specific inventors are not mentioned in the provided source, the priority date for this patent is crucial for understanding its place in the patent timeline. The priority date indicates when the initial application was filed, which can be important for determining the novelty and non-obviousness of the invention.

Claims Analysis

Independent and Dependent Claims

The patent includes both independent and dependent claims. Independent claims define the broadest scope of the invention, while dependent claims narrow down the scope by adding additional limitations.

  • Independent Claims: These claims outline the core components of the stabilized compositions, including the use of volatile alkylating agents such as nitrogen mustard or its HX salts, and the presence of pharmaceutically acceptable excipients.
  • Dependent Claims: These claims specify additional details such as the types of salts, the method of preparation, and the specific applications (e.g., treating skin disorders or cancer).

Claim Scope

The claims are structured to cover a range of aspects:

  • Composition Claims: These claims describe the stabilized compositions themselves, including the active ingredients and excipients.
  • Method Claims: These claims cover the methods of preparing and using the stabilized compositions.
  • Use Claims: These claims specify the intended uses of the compositions, such as treating skin disorders or cancer[4].

Prior Art and Novelty

Prior Art Keywords

The patent lists several prior art keywords, including "nitrogen mustard," "pharmaceutically acceptable," "acid," and "salt." These keywords indicate the existing knowledge in the field that the patent builds upon or distinguishes itself from[4].

Novelty and Non-Obviousness

The patent's novelty and non-obviousness are established by the unique combination of volatile alkylating agents with specific excipients to create a stabilized composition. This combination is not found in the prior art, making the invention novel and non-obvious.

Patent Landscape

Related Patents and Applications

To understand the broader patent landscape, it is essential to search for related patents and applications. Tools like the USPTO's Patent Public Search, Global Dossier, and international patent databases can be used to identify similar inventions and their status[1].

Competitive Analysis

A competitive analysis involves identifying other patents and applications in the same field. For example, searching the European Patent Office's esp@cenet or the World Intellectual Property Organization's PATENTSCOPE can reveal similar compositions or methods being developed by other entities[1].

International Protection

Global Patent Family

The Global Dossier service provided by the USPTO allows users to view the patent family for a specific application, including related applications filed at participating IP Offices. This can help in understanding the international protection and the status of the patent in different jurisdictions[1].

Economic and Legal Implications

Market Impact

The economic implications of this patent can be significant, especially in the pharmaceutical and medical treatment sectors. The stabilized compositions could offer improved treatments for skin disorders and cancer, potentially disrupting existing markets and creating new opportunities.

Legal Considerations

The legal implications involve ensuring that the patent does not infringe on existing patents and that it complies with all relevant regulations. The study on a potential small claims patent court by the Administrative Conference of the United States (ACUS) highlights the importance of efficient legal mechanisms for resolving patent disputes, which could impact the enforcement and defense of this patent[2].

Data and Statistics

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset can provide insights into the trends and statistics of patent claims, including those related to pharmaceutical and chemical inventions. This dataset can help in understanding the broader context of patent scope and claims in similar fields[3].

Conclusion

United States Patent 8,450,375 represents a significant innovation in the stabilization of volatile alkylating agents for medical treatments. Understanding its scope, claims, and the broader patent landscape is crucial for both the inventors and competitors in the field.

Key Takeaways

  • Unique Composition: The patent covers a unique composition of volatile alkylating agents stabilized with specific excipients.
  • Method and Use Claims: The patent includes claims for the methods of preparation and use of these compositions.
  • International Protection: The patent's global family can be tracked using the Global Dossier service.
  • Economic and Legal Implications: The patent has significant economic and legal implications, including market impact and compliance with regulations.
  • Data and Statistics: The USPTO's Patent Claims Research Dataset provides valuable insights into patent trends and statistics.

FAQs

Q: What is the primary focus of United States Patent 8,450,375? A: The primary focus is on stabilized compositions of volatile alkylating agents and their methods of use, particularly in treating skin disorders and cancer.

Q: How can one search for related patents and applications? A: Tools like the USPTO's Patent Public Search, Global Dossier, and international patent databases such as esp@cenet and PATENTSCOPE can be used.

Q: What is the significance of the Global Dossier service? A: The Global Dossier service allows users to view the patent family for a specific application, including related applications filed at participating IP Offices.

Q: How does the USPTO's Patent Claims Research Dataset help in understanding patent trends? A: The dataset provides detailed information on claims from US patents and applications, including claim-level statistics and document-level statistics, which can help in understanding trends and scope in similar fields.

Q: What are the potential economic implications of this patent? A: The patent could offer improved treatments, potentially disrupting existing markets and creating new opportunities in the pharmaceutical and medical treatment sectors.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Google Patents - US8450375B2: https://patents.google.com/patent/US8450375B2/en

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,450,375

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Helsinn VALCHLOR mechlorethamine hydrochloride GEL;TOPICAL 202317-001 Aug 23, 2013 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,450,375

PCT Information
PCT FiledMarch 14, 2006PCT Application Number:PCT/US2006/009060
PCT Publication Date:September 21, 2006PCT Publication Number: WO2006/099385

International Family Members for US Patent 8,450,375

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1858864 ⤷  Subscribe PA2017026 Lithuania ⤷  Subscribe
European Patent Office 1858864 ⤷  Subscribe CR 2017 00033 Denmark ⤷  Subscribe
European Patent Office 1858864 ⤷  Subscribe 300888 Netherlands ⤷  Subscribe
European Patent Office 1858864 ⤷  Subscribe 122017000059 Germany ⤷  Subscribe
European Patent Office 1858864 ⤷  Subscribe 36/2017 Austria ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.